FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

HIV and AIDS
Human Immunodeficiency Virus and
Acquired Immunodeficiency Syndrome

News Releases--1990's

1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990
Archive: 2000's | 1980's

1999

• FDA Announces New Internet Website to Provide Consumer with Information About Buying Prescription Drugs and Medical Products Online (December 20)
• FDA Takes Action Against Firm Marketing Unapproved Drugs (December 10)
• FDA Issues Health Warning About Sun Orchard Fresh Squeezed Unpasteurized Orange Juice, (November 16)
• FDA Issues Final Rule on OTC Drug Products Containing Colloidal Silver (August 17)
• FDA Announces New Efforts to Help Curb Illegal Prescription Drug Marketing on the Internet (July 30)
• FDA Approves First Home Test for Hepatitis C Virus (April 29)
• FDA Approves Agenerase (amprenavir) for HIV Infection (April 16)
• Dietary Supplements Now Labeled with More Information (March 23)
• FDA warns about products containing Gamma Buryrolactone or GBL and asks companies to issue a recall. FDA has received reports of serious health problems - some that are potentially life-threatening-- associated wit the use of these products. (January 21)

1998

• FDA Approves Abacavir for HIV-1 Infection (December 18)
• FDA Approves New Drug to Treat HIV, AIDS(September 18)
• FDA Approves Thalidomide for Hansen's Disease, Side Effect Imposes Unprecedented Restrictions on Distribution (July 16)
• FDA Strengthens Warning Label for  Propulsid (June 29)
• FDA Proposes Rules For Dissemination of Information on Off-Label Uses (June 5)
• FDA Approves Alternative to Fresh Frozen Plasma (May 6)
• Important New Safety Information About Hismanal, (February 9)
• FDA Issues Draft Guidance on the Promotional Practices of Pharmacy Benefit Companies (January 5)

1997

• FDA Scientists Discover Key Mechanism Regulating Immune Cell Activity (December 2)
• FDA Scientists Uncover Factors in the Selective Nature of Sexually-Transmitted HIV (December 2)
• FDA Approves New Formulation of First Protease Inhibitor Saquinavir (November 7)
• Vice Presidential Award Presented to FDA's District Office and Merck & Company, Inc. (October 25)
• Latex Labeling Required for Medical Devices (September 30)
• FDA Warns Consumers About Two Unapproved Home-Use Test Kits (September 26)
• FDA Proposes Rule on Women in Clinical Trials (September 23)
• FDA Proposes to Require Pediatric Data Prior to Drug and Biologic Product Approvals (August 13)
• FDA Warns Consumers on Dangerous Products Promoted on the Internet (June 17)
• FDA Issues National Warning on Hommus Dips and Salads Made By Cedar's Mediterranean Foods (June 12)
• Health Advisory for Newest Class of AIDS Drugs (June 11)
• FDA Approves First Protease Inhibitors with Labeling For Use in Children (March 14)
• Reinventing the Regulation of Human Tissue (February 28)

1996

• New Xenotransplantation Guideline Available (September 20)
• FDA Approves Drug for AIDS-Wasting (August 23)
• FDA Approves First Urine-Based HIV Test (August 6)
• First Group O HIV Infection Reported in the United States (July 5)
• FDA Approves Cidofovir for AIDS-related Retinitis (June 27)
• FDA Approves Nevirapine to Treat HIV (June 24)
• FDA Approves First HIV Home Test System (May 14)
• FDA Approves First Test for HIV Antigen Screening of Blood Donors (March 14)
• FDA Panel Recommends Approval of Third Protease Inhibitor (March 8)
• FDA Panel Recommends Approval of Third Protease Inhibitor (March 8)
• FDA Approves Second Protease Inhibitor to Treat HIV (March 1)
• Thalidomide Update (February 26)
• FDA Advisory Committee to Discuss Various AIDS Treatments (February 2)
• FDA 1995 Approvals Show Continued Decline in Review Times (January 16)

1995

• FDA Approves First Protease Inhibitor Drug for Treatment of HIV (December 7)
• FDA Reforms (November 21)
• FDA Grants Accelerated Approval for 3TC with AZT to Treat AIDS (November 20)
• FDA Panel Recommends Approval of New AIDS Drug (November 15)
• FDA Panel Recommends Approval of 3TC with AZT to Treat AIDS  (November 7)
• FDA Announces Informed Consent Proposals for Experimental Therapies (September 21)
• FDA Expands Access to Investigational Treatment for CMV Retinitis (September 1)
• FDA Announces Patient Education Program (August 23)
• FDA Takes Steps to Increase Safety of U.S. Blood Supply (August 10)
• The Safety of Blood and Blood Products (July 12)
• FDA Public Hearing on Autologous Cells (July 5)
• FDA Revises Blood Donor Criteria to Exclude Prisoners (June 9)
• FDA Cautions Consumers on Kombucha Mushroom Tea (March 23)
• Rules Proposed for Spermicides (February 3)
• Today Sponge (January 12)

1994

• Statement on FDA Approval of AIDS Virus Test System Based on Oral Fluid Samples (December 23)
• FDA Approves Silicone Oil for Retinal Reattachment (November 7)
• Advisory Committee Meets on Accelerated Approval, Expanded Access (September 13)
• AZT Approved for Preventing Maternal Fetal HIV Transmission (August 8)
• Approval of Stavudine d4T (June 27)
• Media Advisory; Task Force on AIDS Drug Development to Meet (April 13)
• FDA Drug and Biologics Approvals 1993 (January 13)
• FDA Licenses IGIV for Two New Indications (January 3)

1993

• Trimetrexate Approved for Treatment of PCP (December 20)
• Latex Condom Study Flawed (October 12)
• FDA Proposes Improvements for Blood Supply (July 1)
• Safety of the Blood Supply (May 3)
• Approval with Restrictive Labeling the Reality Female Condom (April 26)
• Partial Results of AZT Study Reported in Lancet (April 2)

1992

• The FDA today announced the approval of rifabutin (December 23)
• New rules to speed the approval of drugs for patients with serious or life-threatening illnesses such as AIDS, cancer and Alzheimer's disease (December 8)
• Atovaquone Receives Approval for Treatment of PCP (November 27)
• Frequent or persistent cases of vaginal fungal infections or vaginal candidiasis may sometimes be an early warning of HIV infection (November 16)
• Latex Allergies Focus of Government Conference (October 26)
• First AIDS Drug Tested Under Parallel Track Policy (October 5)
• ddI Receives Additional Approval (October 1)
• AIDS Drug Zalcitabine (ddC) (June 22)
• Rapid AIDS Test Licensed (May 27)
• Advisory Committee Recommends Approval of DDC as Combination AIDS Therapy (April 21)
• No AIDS Risk from Polio Vaccines (April 6)
• FDA Approves New More Sensitive Hepatitis C Antibody Test (March 13)
• Rifabutin Receives Treatment IND Status for AIDS Related Use (March 6)
• FDA Urges Buyers Clubs to End Sales of Underground DDC (February 6)
• FDA Advisory Panel Recommends Conditional Approval for Vaginal Pouch (January 31)
• Drugs Approved in 1991 (January 15)
• FDA Issues Import Alert Against Unapproved Mail Order Drugs from Overseas (January 30)
• Dr David W. Feigal Named as New Director of the Division of Antiviral Drug Products (January 7)

1991

• FDA's approval of Dideoxyinosine (ddI) (October 9)
• Ampligen Treatment IND Withheld (October 4)
• Foscarnet Approved (September 27)
• First Combination Test Kit Licensed for Detecting HIV-1 and HIV-2 (September 26)
• Advisory Committee Recommends Approval for AIDS Drug (July 19)
• Epitope to Cease Marketing of AIDS Test Kit (July 10)
• ddC Receives IND status (June 13)
• Foscarnet Recommendation (June 12)
• New AZT Data Reviewed (February 14)
• Drugs Approved in 1990 (January 17)
• Book on Importing Drugs (January 9)
• Factor IX (January 3)
• EPO for AIDS-Related Condition (January 2)

1990

• Plastic Glove Test Methods (December 12)
• New Blood Policy (December 5)
• AIDS Update (October 30)
• Opposition to Home Collection Kit for AIDS (July 19)
• Isoprinosine Update (June 21)
• AZT for Children (May 3)
• HIV-2 Test Kit Approved (April 25)
• Treatment IND Update (March 20)
• Advisory Committee Meeting on HIV-2 and EPO (March 15)
• Expanded Labeling for AZT (March 2)
• AIDS Meeting (January 30)
• Drugs Approved in 1989 (January 16)

HIV/AIDS Home Page

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Office of Special Health Issues